Wang Weigang, Sun Yangle, Li Jinbo, Bai Hongjing, Ren Chaomin, Feng Yongliang, Wang Suping
Department of Epidemiology, School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan, 030001, China.
Shanxi Province Cancer Hospital, Taiyuan, China.
BMC Cancer. 2025 Jun 6;25(1):1015. doi: 10.1186/s12885-025-14416-1.
The issue of breast cancer in young women (BCYW) has gained increasing attention over the past few decades. However, a notable gap exists in the literature concerning the comparison of the disease burden of BCYW with that of other age groups. This study presents a comprehensive analysis of the disparities in global, regional, and national burden between BCYW and their middle-aged and elderly counterparts.
The breast cancer data in this study were collected from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 (GBD 2021). The age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), age-standardized prevalence rate (ASPR), and age-standardized disability-adjusted life years rate (ASDR), and the Average Annual Percent Change (AAPC) were employed to assess the disease burden of BCYW. The Bayesian Age-Period-Cohort model was used to forecast disease burden from 2022 to 2030.
The AAPC of ASIR of BCYW from 1990 to 2021 was 0.91 (95% CI: 0.77 to 1.05), exceeding the global average (0.49, 95% CI: 0.40 to 0.58) as well as both middle-aged (0.60, 95% CI: 0.47 to 0.73) and elderly groups (0.30, 95% CI: 0.21 to 0.39). The AAPC for ASMR of BCYW experienced a marginal increase of 0.02 (95%CI: -0.07 to 0.11) from 1990 to 2021, surpassing the rates observed in both the middle-aged group (-0.40, 95%CI: -0.47 to -0.32) and the elderly group (-0.50, 95%CI: -0.62 to -0.38). The ASIR in BCYW significantly increased in regions with low (AAPC = 1.87), low-middle (AAPC = 2.32), middle (AAPC = 1.84), and high-middle SDI (AAPC = 0.98), while it remained unchanged in regions with high SDI (AAPC = -0.02). This trend was also observed among middle-aged and older groups. The ASMR in BCYW significantly increased in regions with low (AAPC = 1.01) and low-middle SDI (AAPC = 1.25), but remained unchanged in regions with middle SDI (AAPC = 0.02), while it decreased in regions with high-middle (AAPC = -1.10) and high SDI (AAPC = -1.60). Among the middle-aged and elderly populations, there was an increase in ASMR rates observed in regions with low, low-middle, and middle SDI groups (all AAPC > 0), whereas a decrease was noted in the regions with high-middle and high SDI (all AAPC < 0). The BAPC predicts a consistent annual increase in ASIR, ASMR, ASPR, and ASDR of BCYW globally and in China from 2022 to 2030. Notably, China has higher ASIR and ASPR rates compared to the global average, while its ASMR and ASDR rates are lower.
The burden of BCYW was particularly significant in regions with low-SDI, low-middle SDI, and middle SDI. Despite the progress made, China still faces considerable challenges in effectively addressing this issue. The prevention and control of BCYW must remain a priority. Different countries and regions should develop personalized, targeted intervention strategies for this population and establish public health policies tailored to the specific needs of each region.
在过去几十年中,年轻女性乳腺癌(BCYW)问题日益受到关注。然而,关于BCYW与其他年龄组疾病负担比较的文献存在显著空白。本研究全面分析了BCYW与其中年和老年对应人群在全球、区域和国家层面负担的差异。
本研究中的乳腺癌数据来自《2021年全球疾病、伤害和风险因素研究》(GBD 2021)。采用年龄标准化发病率(ASIR)、年龄标准化死亡率(ASMR)、年龄标准化患病率(ASPR)、年龄标准化残疾调整生命年率(ASDR)以及年均变化百分比(AAPC)来评估BCYW的疾病负担。使用贝叶斯年龄-时期-队列模型预测2022年至2030年的疾病负担。
1990年至2021年,BCYW的ASIR的AAPC为0.91(95%CI:0.77至1.05),超过全球平均水平(0.49,95%CI:0.40至0.58)以及中年组(0.60,95%CI:0.47至0.73)和老年组(0.30,95%CI:0.21至0.39)。1990年至2021年,BCYW的ASMR的AAPC略有增加,为0.02(95%CI:-0.07至0.11),超过中年组(-0.40,95%CI:-0.47至-0.32)和老年组(-0.50,95%CI:-0.62至-0.38)的增长率。BCYW的ASIR在低社会人口指数(SDI)地区(AAPC = 1.87)、低-中SDI地区(AAPC = 2.32)、中等SDI地区(AAPC = 1.84)和高-中SDI地区(AAPC = 0.98)显著增加,而在高SDI地区保持不变(AAPC = -0.02)。中年和老年组也观察到了这种趋势。BCYW的ASMR在低SDI地区(AAPC = 1.01)和低-中SDI地区(AAPC = 1.25)显著增加,但在中等SDI地区保持不变(AAPC = 0.02),而在高-中SDI地区(AAPC = -1.10)和高SDI地区(AAPC = -1.60)下降。在中年和老年人群中,低、低-中、中等SDI组地区的ASMR率有所上升(所有AAPC>0),而在高-中、高SDI地区有所下降(所有AAPC<0)。BAPC预测,2022年至2030年全球及中国BCYW的ASIR、ASMR、ASPR和ASDR将持续逐年上升。值得注意的是,中国的ASIR和ASPR率高于全球平均水平,而ASMR和ASDR率较低。
BCYW的负担在低SDI、低-中SDI和中等SDI地区尤为显著。尽管取得了进展,但中国在有效应对这一问题方面仍面临巨大挑战。BCYW的预防和控制必须仍然是优先事项。不同国家和地区应针对这一人群制定个性化、有针对性的干预策略,并制定符合每个地区特定需求的公共卫生政策。